FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Macleods Pharma Levofloxacin Tablets Recall

Levofloxacin Tablets, USP 500 mg

MACLEODS PHARMA USA, INC · Princeton, NJ

Risk level
Class III
Reported by FDA
Jan 25, 2023
Recall ID
D-0162-2023
Check your lot numberHow we source this data

Summary

Macleods Pharma recalled Levofloxacin Tablets starting Jan 5, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0162-2023 on Jan 25, 2023. Reason: Mismatching of the embossing on the tablets (T7) with the embossing mentioned in the package insert (ML63) in the distributed bottles. Status: Terminated.

Why it was recalled

Mismatching of the embossing on the tablets (T7) with the embossing mentioned in the package insert (ML63) in the distributed bottles.

Product description

Levofloxacin Tablets, USP 500 mg; 50-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540; Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India. NDC 33342-022-08

Lot numbers, UPCs & expiration codes

Lot #: BLF2214A; Exp. 06/2025

Where it was sold

Nationwide within United States and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0162-2023
Classification
Class III
Status
Terminated
Recall initiated
Jan 5, 2023
FDA report date
Jan 25, 2023
Quantity
10052 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
MACLEODS PHARMA USA, INC

Original FDA data

Every field from FDA enforcement report D-0162-2023, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
91441
Address
103 College Rd E Fl 2
Code information
Lot #: BLF2214A; Exp. 06/2025
Postal code
08540-6611
Report date
Jan 25, 2023
Product type
Drugs
Recall number
D-0162-2023
Classification
Class III
Recalling firm
MACLEODS PHARMA USA, INC
Product quantity
10052 bottles
Termination date
Jun 24, 2025
Reason for recall
Mismatching of the embossing on the tablets (T7) with the embossing mentioned in the package insert (ML63) in the distributed bottles.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Levofloxacin Tablets, USP 500 mg; 50-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540; Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India. NDC 33342-022-08
Distribution pattern
Nationwide within United States and Puerto Rico.
Recall initiation date
Jan 5, 2023
Initial firm notification
Letter
Center classification date
Jan 17, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0162-2023, published Jan 25, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls